Blocking TMEM141 Reduces MASH and Fibrosis Through ROS-HNF4α Pathway
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
In a groundbreaking study poised to reshape our understanding of liver metabolism and cellular stress response, researchers have unveiled the ...
In a groundbreaking development that promises to reshape our understanding of metabolic disorders and fibrotic diseases, researchers have unveiled the ...
In a groundbreaking study published in Nature Communications, researchers have unveiled a novel mechanistic link between the pathogenic bacterium Helicobacter ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine